INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,000 | -60.0% | 6,988 | -22.7% | 0.00% | – |
Q1 2022 | $10,000 | -50.0% | 9,038 | 0.0% | 0.00% | – |
Q4 2021 | $20,000 | -35.5% | 9,038 | 0.0% | 0.00% | – |
Q3 2021 | $31,000 | +14.8% | 9,038 | 0.0% | 0.00% | – |
Q2 2021 | $27,000 | -95.1% | 9,038 | -97.4% | 0.00% | – |
Q2 2017 | $548,000 | +1145.5% | 349,346 | +2430.0% | 0.00% | – |
Q1 2017 | $44,000 | +76.0% | 13,808 | -25.5% | 0.00% | – |
Q4 2016 | $25,000 | +127.3% | 18,534 | +154.6% | 0.00% | – |
Q3 2016 | $11,000 | +10.0% | 7,279 | 0.0% | 0.00% | – |
Q2 2016 | $10,000 | -74.4% | 7,279 | 0.0% | 0.00% | – |
Q1 2016 | $39,000 | -30.4% | 7,279 | 0.0% | 0.00% | – |
Q4 2015 | $56,000 | -5.1% | 7,279 | 0.0% | 0.00% | – |
Q3 2015 | $59,000 | -22.4% | 7,279 | 0.0% | 0.00% | – |
Q2 2015 | $76,000 | -28.3% | 7,279 | 0.0% | 0.00% | – |
Q1 2015 | $106,000 | -14.5% | 7,279 | 0.0% | 0.00% | – |
Q4 2014 | $124,000 | +18.1% | 7,279 | -5.0% | 0.00% | – |
Q3 2014 | $105,000 | – | 7,659 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |